Austex

Singapore, Singapore Founded: 2016 • Age: 10 yrs
Produces and sells pharmaceutical products like antibiotics and multivitamins globally.
Annual revenue $902,623 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 7 Services tracked
Competitors - Brand Intelligence

About Austex

Austex is a company based in Singapore (Singapore) founded in 2016. It operates as a B2C and B2B. Austex offers products and services including AUSCEPO, AUSICEFT XP, AUSITUM CV, AUSMERO SB, and AUSZACT.

  • Headquarter Singapore, Singapore
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Austex Pharmaceutical Private Limited
  • Date of Incorporation 26 Sep, 2016
  • Jurisdiction Bally Jagachha, West Bengal, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $902.62 K (USD)
    35.76
    as on Mar 31, 2023
  • Net Profit
    -$461.83 K (USD)
    2.06
    as on Mar 31, 2023
  • EBITDA
    $105.75 K (USD)
    123.82
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Austex

Austex offers a comprehensive portfolio of products and services, including AUSCEPO, AUSICEFT XP, AUSITUM CV, AUSMERO SB, and AUSZACT.

Product name locked
Category locked
Primary

Antibiotic for treating infections with economical formulation.

Product name locked
Category locked
Locked

Injection for bacterial infections and related treatments.

Product name locked
Category locked
Locked

Medication for combating tough pathogens effectively.

Product name locked
Category locked
Locked

Injection used in severe infection management.

Product name locked
Category locked
Locked

Injections for various bacterial conditions.

Product name locked
Category locked
Locked

Supplement to address fatty liver and nutritional needs.

Product name locked
Category locked
Locked

Relief for acidity and gas-related digestive issues.

Funding Insights of Austex

Premium access

Detailed funding history for Austex

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Austex

Investments
Premium access

Investment portfolio details for Austex

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Austex

Premium access

Detailed financials for Austex

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Austex Comparisons

Austex Primary company
Description
Produces and sells pharmaceutical products like antibiotics ...
Location
Singapore, Singapore
Founded Year
2016
Annual Revenue
$902.62 K (USD)
Net Profit
-$461.83 K (USD)
EBITDA
$105.75 K (USD)
Employees
Not available
Premium access

Peer comparison for Austex

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Austex

Premium access

Detailed competitors of Austex

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Austex

Premium access

Complete news archive for Austex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Austex

Austex was founded in 2016.

Austex is headquartered in Singapore, Singapore.

Annual revenue of Austex is $902.62K as on Mar 31, 2023.

Austex Pharma is a pharmaceutical company that manufactures generic medicines, including antibiotics, antifungals, and multivitamins, using certified facilities. It operates from headquarters in Singapore and regional offices in India, such as Kolkata, Patna, and Varanasi. The company aims to provide affordable, high-quality drugs while ensuring ethical practices and global distribution through retail and corporate channels. It emphasizes employee development and corporate social responsibility initiatives.

Austex offers AUSCEPO, AUSICEFT XP, AUSITUM CV, AUSMERO SB, and 3 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available